FDA Regulatory Doctor

FDA Regulatory Doctor

Providing Important FDA Food Drug and Medical Device and FDA Inspection Information

Menu

  • Home
  • Register
  • About Us
  • Industry
  • 510k Clearances
  • VIDEO
    • [Educational Video] Robotic Prostatectomy
    • [Educational Video] Face Transplant Surgery Story
    • [Medical Video] Attention Deficit Hyperactivity Disorder (ADHD)
    • [CDC] Salt Matters
    • What Is Vascular Dementia?
    • On the Go with Diabetes
    • Medical Video for Parkinson’s Disease (PD)
    • Hereditary Breast and Ovarian Cancers: Genetic Testing
    • Exercise Therapy Acupuncture May Help Breast Cancer Survivors
    • [Video] American Diabetes Association: Healthy Breakfast
  • Books
    • Clinical Trials
    • Quality Control Quality Management Regulatory and Clinical Affairs

Bipolar I

Newly Identified Proteins Offer New Insight Into Bipolar I Disorder

Newly Identified Proteins Offer New Insight Into Bipolar I Disorder

New Insight into Diagnostic Tool for Mood Disorder Mayo Clinic Presents the Following Video According to the following publication, a series of proteins has been identified to offer insight into a mood disorder (Bipolar I).  According to findings, these proteins

Staff Editor December 12, 2015 Bipolar I Read more

Recent Posts

  • Learn about Egg Safety
  • Johnson and Johnson Baby Powder May Be Linked to Cancer
  • Johnson and Johnson Baby Power May Be Linked to Cancer
  • Understanding Essure Problems and Hysterectomy
  • FDA Action for Essure Safety and Potential Risks
  • FDA Announcement about Essure
  • Get a Free Heart Health Kit for Women
  • FDA Is Reminding Consumers for Laser Pointer Safety
  • Educational Animation for Total Hip Replacement Surgery
  • Newly Identified Proteins Offer New Insight Into Bipolar I Disorder

RSS Food and Drug Administration–Press Releases

  • Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Frank Yiannas on new findings and updated consumer recommendations related to the romaine lettuce <i>E. coli</i> O157:H7 outbreak investigation
  • Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice
  • FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework
  • Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data
  • FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
  • Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

Recent Posts

  • Learn about Egg Safety
  • Johnson and Johnson Baby Powder May Be Linked to Cancer
  • Johnson and Johnson Baby Power May Be Linked to Cancer
  • Understanding Essure Problems and Hysterectomy
  • FDA Action for Essure Safety and Potential Risks
  • FDA Announcement about Essure
  • Get a Free Heart Health Kit for Women
  • FDA Is Reminding Consumers for Laser Pointer Safety
  • Educational Animation for Total Hip Replacement Surgery
  • Newly Identified Proteins Offer New Insight Into Bipolar I Disorder
  • Learn about the Potential Risks of LASIK Surgery
  • Management and Outcomes of Binge-Eating Disorder
  • Animated Central Nervous System
  • Blood Clot Formation and Anticoagulant Drugs
  • Our Gut Bacteria May Be the Cause for Metabolic Disease and Obesity
  • Heart Disease and Diabetes
  • Learn When to Go to ER or Urgent Care
  • Pigeons Can Detect Cancer
  • Learn What Vaccines You Need from CDC
  • FDA Meeting Materials for NDA 206031 Drisapersen Solution for injection

RSS Quest for Regulatory Compliance

  • St Jude Files Suit- St. Jude v. Muddy Waters Consulting LLC and Others
  • Former FDA Commissioner and Her Husband Sued Over Drug Levaquin
  • BSC Is Recalling Fetch 2 Aspiration Catheter Due to Shaft Breakage
  • 2016 February MDRs for Essure
  • FDA Safety Alert for EOS Lip Balm Products
  • FDA Warned A Drug Manufacturer for Data Falsification
  • FDA Video on the Laser Pointers for Risk of Eye and Skin Injuries
  • US Supreme Court Justice Dies During Vacation in Texas
  • Pfizer Hit with False and Misleading Video for Precedex
  • US Enters Consent Decree Against Texas Drug Manufacturer

Login Status

You are not logged in.
Forgot?  Register

RSS FDA Guidance Information

  • FDA Guidance on Expansion of the Abbreviated 510k Program
  • Completeness Assessments for Type II API DMFs Under GDUFA
  • Use of ISO 10993-1 for Medical Device Risk Management Process
  • FDA Data Integrity and Compliance with CGMP
  • ANDA Submissions-Content and Format

Copyright © 2016. FDA DOCTOR. All Rights Reserved.